ExSAR Corporation

11 Deer Park Drive, Suite 103
Monmouth Junction
United States of America, New Jersey

Phone: 732-438-6500


ExSAR is now a clinical developmental stage company dedicated to identifying, developing and commercializing small-molecule therapeutics for diseases of protein conformation.

As a leader in the application of Hydrogen/Deuterium exchange technology, ExSAR provides H/D-Ex technology services to third parties. In this capacity, ExSAR offers epitope mapping services in support of monoclonal therapeutic antibody development. ExSAR also employs hydrogen/deuterium exchange to characterize proteins, including biogenerics and to identify ligand binding sites, typically in conjunction with fragment based drug discovery programs.